Stentys: 41% Increase In Revenues In The Second Quarter Of 2016

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Regulatory News:

STENTYS (FR0010949404 - STNT) (Paris:STNT), a medical technology company commercializing the world's first and only Self-Apposing® coronary stent, today announces its revenues and cash position at June 30, 2016.